# US 2021/0275733 A1 · Measurement of Body Fluid Retention using Inductive Coupling

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275733 A1
- Document ID: US20210275733A1
- Status: Published application
- Kind: A1
- Application number: 16/809,618
- Filed: 2020-03-05
- Published: 2021-09-09
- Earliest claimed: 2020-03-05
- Assignees: Vectorious Medical Technologies Ltd.
- Applicants: Vectorious Medical Technologies Ltd.
- Inventors: Oren Goldshtein; Matan Hershko
- Web page: https://patentgrep.com/patent/US20210275733A1

## CPC

- A61B 5/6869: {Heart}
- G01R 33/02: Measuring direction or magnitude of magnetic fields or magnetic flux (G01R33/20 takes precedence)
- A61B 5/0215: by means inserted into the body
- A61B 5/05: Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves (measuring movement of the entire body or parts thereof A61B5/11; detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof A61B5/24)
- A61B 5/4875: {Hydration status, fluid retention of the body}
- G01R 33/0094: {Sensor arrays}
- A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)}
- A61M 2205/04: implanted
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An apparatus includes a magnetic-field transducer, and circuitry. The magnetic-field transducer is configured to be coupled externally to a body of a patient. The circuitry is configured to generate and apply to the magnetic-field transducer a time-varying signal, so as to generate a time-varying magnetic field outside the body of the patient, for supplying electrical energy by inductive coupling to an electronic device that is positioned inside the body, to estimate an intensity of the magnetic field that reaches the electronic device, and to assess fluid retention in an organ of the patient based on the estimated intensity of the magnetic field.

## Claims

### Claim 1

An apparatus, comprising:
a magnetic-field transducer, which is configured to be coupled externally to a body of a patient; and
circuitry, configured to:
generate and apply to the magnetic-field transducer a time-varying signal, so as to generate a time-varying magnetic field outside the body of the patient, for supplying electrical energy by inductive coupling to an electronic device that is positioned inside the body;
estimate an intensity of the magnetic field that reaches the electronic device; and
assess fluid retention in an organ of the patient based on the estimated intensity of the magnetic field.

### Claim 2 (depends on 1)

The apparatus according to claim 1, wherein the circuitry is configured to initiate a responsive action upon detecting that the fluid retention is indicative of an abnormality.

### Claim 3 (depends on 1)

The apparatus according to claim 1, wherein the organ comprises a lung of the patient.

### Claim 4 (depends on 1)

The apparatus according to claim 1, wherein the circuitry is configured to receive, from the electronic device, data indicative of the intensity of the magnetic field that reaches the electronic device, and to estimate the intensity based on the data.

### Claim 5 (depends on 4)

The apparatus according to claim 4, wherein the data comprises an indication of whether the intensity of the magnetic field exceeds a predefined threshold.

### Claim 6 (depends on 4)

The apparatus according to claim 4, wherein the circuitry is configured to assess the fluid retention by adaptively adjusting a power level of the magnetic field applied to the magnetic-field transducer depending on the data.

### Claim 7 (depends on 1)

The apparatus according to claim 1, wherein the circuitry is configured to assess the fluid retention by adaptively adjusting a power level of the magnetic field applied to the magnetic-field transducer, and identifying a minimal power level that invokes a response from the electronic device.

### Claim 8 (depends on 1)

The apparatus according to claim 1,
wherein the electronic device transfers data to outside the body by modulating the induction-coupled magnetic field, and
wherein the circuitry is configured to estimate the intensity of the magnetic field that reaches the electronic device by measuring the modulated magnetic field outside the body.

### Claim 9 (depends on 1)

The apparatus according to claim 1,
wherein the electronic device transfers a value to outside the body by resonating at a frequency that is indicative of the value, and
wherein the circuitry is configured to estimate the intensity of the magnetic field that reaches the electronic device by measuring the magnetic field outside the body while the electronic device is resonating.

### Claim 10 (depends on 1)

The apparatus according to claim 1, wherein the circuitry is configured to receive from the electronic device one or more blood pressure measurements in a heart of the patient, and to initiate a responsive action upon detecting that a combination of the fluid retention and the blood pressure measurements is indicative of an abnormality.

### Claim 11

A system, comprising:
a transformer comprising a primary coil and a secondary coil, wherein one of the primary coil and the secondary coil is configured to be positioned inside a body of a patient, and the other of the primary coil and the secondary coil is configured to be positioned externally to the body; and
circuitry, configured to:
estimate a measure of magnetic-field inductive-coupling between the primary coil and the secondary coil of the transformer; and
assess fluid retention in an organ of the patient based on the estimated measure of the magnetic-field inductive-coupling.

### Claim 12 (depends on 11)

The system according to claim 11, wherein the circuitry is configured to initiate a responsive action upon deciding that the assessed fluid retention is indicative of an abnormality.

### Claim 13

A method, comprising:
generating and applying a time-varying signal to a magnetic-field transducer coupled externally to a body of a patient, so as to generate a time-varying magnetic field outside the body of the patient, for supplying electrical energy by inductive coupling to an electronic device that is positioned inside the body;
estimating an intensity of the magnetic field that reaches the electronic device; and
assessing fluid retention in an organ of the patient based on the estimated intensity of the magnetic field.

### Claim 14 (depends on 13)

The method according to claim 13, further comprising initiating a responsive action upon detecting that the fluid retention is indicative of an abnormality.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the organ comprises a lung of the patient.

### Claim 16 (depends on 13)

The method according to claim 13, wherein estimating the intensity of the magnetic field comprises receiving, from the electronic device, data indicative of the intensity of the magnetic field that reaches the electronic device, and estimating the intensity based on the data.

### Claim 17 (depends on 16)

The method according to claim 16, wherein receiving the data comprises receiving an indication of whether the intensity of the magnetic field exceeds a predefined threshold.

### Claim 18 (depends on 16)

The method according to claim 16, wherein assessing the fluid retention comprises adaptively adjusting a power level of the magnetic field applied to the magnetic-field transducer depending on the data.

### Claim 19 (depends on 13)

The method according to claim 13, wherein assessing the fluid retention comprises adaptively adjusting a power level of the magnetic field applied to the magnetic-field transducer, and identifying a minimal power level that invokes a response from the electronic device.

### Claim 20 (depends on 13)

The method according to claim 13,
wherein the electronic device transfers data to outside the body by modulating the induction-coupled magnetic field, and
wherein estimating the intensity of the magnetic field that reaches the electronic device comprises measuring the modulated magnetic field outside the body.

### Claim 21 (depends on 13)

The method according to claim 13,
wherein the electronic device transfers a value to outside the body by resonating at a frequency that is indicative of the value, and
wherein estimating the intensity of the magnetic field that reaches the electronic device comprises measuring the magnetic field outside the body while the electronic device is resonating.

### Claim 22 (depends on 13)

The method according to claim 13, further comprising receiving from the electronic device one or more blood pressure measurements in a heart of the patient, and initiating a responsive action upon detecting that a combination of the fluid retention and the blood pressure measurements is indicative of an abnormality.

### Claim 23

A method, comprising:
estimating a measure of magnetic-field inductive-coupling between a primary coil and a secondary coil of a transformer, wherein one of the primary coil and the secondary coil is positioned inside a body of a patient, and the other of the primary coil and the secondary coil is positioned externally to the body; and
assessing fluid retention in an organ of the patient based on the estimated measure of the magnetic-field inductive-coupling.

### Claim 24 (depends on 23)

The method according to claim 23, further comprising initiating a responsive action upon deciding that the assessed fluid retention is indicative of an abnormality.
